Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial.

Uffmann, Madita

Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial. [electronic resource] - Blood 06 2017 - 3314-3321 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood-2017-01-765057 doi


Antineoplastic Agents--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Child, Preschool
Chromosomes, Human, Pair 8--genetics
Cytarabine--adverse effects
Cytogenetic Analysis
Disease-Free Survival
Down Syndrome--complications
Etoposide--adverse effects
Female
Humans
Idarubicin--adverse effects
Infant
Leukemia, Myeloid--complications
Male
Prospective Studies
Treatment Outcome
Trisomy--genetics